Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
fig.S3.a
Mimoto MS et al. (2015) |
Xla Wt + gata2 MO
NF15 (real time PCR) |
|
||||
fig.S3.a
Mimoto MS et al. (2015) |
Xla Wt + gata2 MO
NF18 (real time PCR) |
|
||||
fig.S4
Mimoto MS et al. (2015) |
Xla Wt + LiCl
NF32 (in situ hybridization) |
|
||||
fig.7.a
Mimoto MS et al. (2015) |
Xla Wt + dndvl2-GFP
NF35/36 (in situ hybridization) |
|
||||
Fig. 7 B e-g, l-n; Fig. 7 C o
Buisson I et al. (2015) |
Xla Wt + pax8 MO
NF25 (in situ hybridization) |
|||||
fig.7.k
Costa RM et al. (2008) |
Xla Wt + spib MO
NF22 (in situ hybridization) |
|
||||
fig.7.l
Costa RM et al. (2008) |
Xla Wt + spib MO
NF22 (in situ hybridization) |
|